EUVIMEDEUVIMED entdecken
Crossref

Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles

Sholeh Feizi iD, Muhammed Awad, Mahnaz Ramezanpour, Clare Cooksley, William Murphy, Clive A Prestidge iD, Alkis J Psaltis, Peter-John Wormald, Simone Barry, Sarah Vreugde iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c15843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Sholeh Feizi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health N…. Hauptthemen laut MEDLINE: Nanoparticles, Gallium, Protoporphyrins, Mycobacterium abscessus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Hospital Research Foundation, National Foundation for Medical Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesGalliumProtoporphyrinsMycobacterium abscessusDeferiproneHumansMycobacterium Infections, NontuberculousAnti-Bacterial AgentsMicrobial Sensitivity TestsLiquid Crystals

Stichwörter der Autor:innen

antimicrobial resistancedeferipronegallium protoporphyrinhemeliquid crystalline nanoparticlesnontuberculous mycobacteria

Substanzen

GalliumProtoporphyrinsDeferiproneprotoporphyrin IXAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.
  • The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
  • Centre for Pharmaceutical Innovation, University of South Australia, Clinical and Health Sciences, Adelaide 5000, Australia.
  • Precision Medicine Theme, South Australian Health and Medical Institute, Adelaide 5000, South Australia, Australia.
  • Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide 5000, South Australia, Australia.

ORCID-Profile: Sholeh Feizi, Clive A Prestidge, Sarah Vreugde

Förderung

  • Hospital Research Foundation
  • National Foundation for Medical Research and Innovation

Zitieren

APA

Feizi, S., Awad, M., Ramezanpour, M., Cooksley, C., Murphy, W., Prestidge, C. A., Psaltis, A. J., Wormald, P. J., Barry, S., & Vreugde, S. (2024). Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c15843

Vancouver

Feizi S, Awad M, Ramezanpour M, Cooksley C, Murphy W, Prestidge CA, et al. Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c15843

BibTeX
@article{Feizi2024,
  author = {Feizi, Sholeh and Awad, Muhammed and Ramezanpour, Mahnaz and Cooksley, Clare and Murphy, William and Prestidge, Clive A and Psaltis, Alkis J and Wormald, Peter-John and Barry, Simone and Vreugde, Sarah},
  title = {Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against Mycobacterium abscessus Intracellular Infection with Lipid Liquid Crystalline Nanoparticles},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c15843}
}
Kostenlos starten →